CHH
Choice Hotels International, Inc.
CHH trails on the overall score without a compensating advantage in the available component scores.
NKE
NIKE, Inc.
NKE has the edge over CHH overall, supported by stronger valuation and stronger modeled upside.
CHH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
CHH's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CHH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $73.78 | -38% |
| Forward | 16x | $118 | — |
| Fair | 21x | $95.93 | -19% |
| Current | 26x | $118 | — |
| Expensive | 35x | $155 | +31% |
Historical ranges are pointers, not guarantees.
CHH's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over CHH in the historical PE scenario, which offers more potential upside but is not a forecast.
CHH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CHH, but weaker profitability.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CHH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +68% |
| Q3 2026 | $4.48 | -45% |
| Q2 2026 | $7.06 | +9.1% |
| Q1 2026 | $7.40 | +13% |
| Q4 2025 | $7.90 | +27% |
| Q3 2025 | $8.11 | +55% |
| Q2 2025 | $6.47 | +34% |
| Q1 2025 | $6.52 | +40% |
| Q4 2024 | $6.20 | +22% |
CHH has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CHH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $458.3M | +2.5% |
| Q2 2026 | $440.8M | +3.4% |
| Q1 2026 | $340.6M | +2.3% |
| Q4 2025 | $390.2M | +0.1% |
| Q3 2025 | $447.3M | +4.5% |
| Q2 2025 | $426.4M | -2% |
| Q1 2025 | $332.9M | +0.3% |
| Q4 2024 | $389.8M | +8.8% |
CHH has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -8.6 points |
| Q2 2026 | 24% | -5.6 points |
| Q1 2026 | 18% | -6.4 points |
| Q4 2025 | 26% | -4.6 points |
| Q3 2025 | 32% | -3.6 points |
| Q2 2025 | 29% | -1.3 points |
| Q1 2025 | 24% | +5.9 points |
| Q4 2024 | 31% | +20 points |
CHH has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
CHH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | -9.7% |
| Q2 2026 | $80.1M | +22% |
| Q1 2026 | -$40M | -$25M |
| Q4 2025 | $64.1M | +12% |
| Q3 2025 | $49.1M | -70% |
| Q2 2025 | $65.4M | -8% |
| Q1 2025 | -$15M | +$16M |
| Q4 2024 | $57.4M | +296% |
CHH has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CHH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -317K shares |
| 1 year | -3% | -1.4M shares |
| 3 years | -11% | -5.4M shares |
| 5 years | -19% | -10.8M shares |
| Available history | -19% | -10.6M shares |
CHH has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $58.7M |
| Q2 2026 | $51M |
| Q1 2026 | $56.5M |
| Q4 2025 | $25.3M |
| Q3 2025 | $202,000 |
| Q2 2025 | $48.1M |
| Q1 2025 | $64.6M |
| Q4 2024 | $31.8M |
CHH spent $192M buying back its own shares over the past year, up 32% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CHH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.4x | Elevated |
CHH's net debt is about 4.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over CHH on leverage, with a lower net debt burden relative to earnings.
CHH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.3 | Neutral |
| Stochastic | 83.8 | Overbought |
CHH's weekly RSI is 62 (neutral) and its Stochastic is 84 (overbought).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CHH PE vs Consumer Cyclical Sector
| Metric | CHH | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 47% above |
| PE % | 65 | 47 | 18 pts above |
CHH is trading at 26x earnings, a 47% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over CHH on valuation relative to its sector.
CHH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.4 | 8.1% above |
| 20 week MA | $107.8 | 9.8% above |
| 50 week MA | $106.2 | 11% above |
| 100 week MA | $115.5 | 2.5% above |
| 200 week MA | $119.2 | 0.8% below |
CHH has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CHH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.9 | $104.1 | -0.8% |
| 2021 | $104.1 | $152.7 | +47% |
| 2022 | $152.7 | $112.2 | -27% |
| 2023 | $112.2 | $113.3 | +1% |
| 2024 | $113.3 | $140.8 | +24% |
| 2025 | $140.8 | $96.0 | -32% |
| 2026 YTD | $96.0 | $118.3 | +23% |
CHH has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.